Delivery Order SPE2DB20D1109-SPE2DB22FQ13B
Award Date
9/21/22
Potential Completion Date
9/22/22
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,291.53 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a medical product. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.38 firm-fixed price delivery order is for the pharmaceutical product Naropin 0.5% 100 mg/20 ml vial, 20 ml, with a performance period ending on December 17, 2024. The contract award was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,099.88 firm fixed-price contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, with a completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563539837 NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $5,221.35. The contract is a firm fixed-price delivery order that runs through February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, with a ceiling value of $1,181.78 and a period of performance through February 21, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition....
This federal contract award, SPE2DX15D3005|SPE2DX24F3QLW, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is for the delivery of the pharmaceutical product Naropin 0.5% 100 mg/20 ml vial, 20 ml, with a firm fixed price ceiling value of $1,435.80 and a performance period through March 29, 2024. This award is not set aside and is part of Amerisourcebergen Drug...
This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medical products to the Defense Logistics Agency (DLA). The $4,945.34 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,805.82 firm fixed-price delivery order contract is for the provision of 4564431836 ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a medical product. The contract has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, issued by the Defense Logistics Agency (DLA), is for the delivery of 4565218282 - Ropivacaine 0.2% 400 mg/200 ml 200 ml, with a ceiling value of $7,880.81. The contract is a Firm Fixed Price Delivery Order with a completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ROPIVACAINE 0.2% 200 MG/100 ML 100ML. The award, valued at $1,634.70, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and runs through February 13, 2025. The award is not subject to any set-aside requirements. Amerisourcebergen holds a...